Analyst firms · Oppenheimer · PMVP
Oppenheimer PMVP price target and rating history
PMV Pharmaceuticals Inc. (PMVP) · Health Care
Oppenheimer rates PMV Pharmaceuticals Inc. (PMVP) Outperform with a $6 price target, as of its latest action on Nov 8, 2024. It has published 4 rating actions on PMVP since August 2021, including 3 upgrades and 0 downgrades.
- Current rating
- Outperform
- Price target
- $6
- Median target, all firms
- Too few
- Actions on PMVP
- 4
Oppenheimer price target on PMVP
Every Oppenheimer rating on PMVP
- Nov 8, 2024
- Mar 2, 2022
- Mar 2, 2022
- Aug 19, 2021
Questions about Oppenheimer and PMVP
- What is Oppenheimer's price target for PMVP?
- Oppenheimer's latest stated price target for PMV Pharmaceuticals Inc. (PMVP) is $6, from its action on Nov 8, 2024.
- What is Oppenheimer's rating on PMVP?
- Oppenheimer rates PMVP Outperform, a bullish rating, as of Nov 8, 2024.
- When did Oppenheimer last change its view on PMVP?
- On Nov 8, 2024, Oppenheimer upgrades to Outperform from Perform, price target $6.
All Oppenheimer ratingsPMVP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.